Failure to Rotate Insulin Sites and Reassess Abnormal Vital Signs
Summary
Insulin injection sites were not rotated for two residents with diabetes. Resident 16 was admitted with type 2 diabetes mellitus with hyperglycemia and was receiving insulin glargine. Review of the February 2026 MAR showed repeated administrations at the same sites, including the right arm, left arm, and left abdominal quadrants. During record review, an LN stated the injection sites were not rotated. Resident 7 was admitted with type 2 diabetes mellitus and muscle weakness and had physician orders for insulin lispro sliding scale and insulin glargine at bedtime with instructions to rotate sites. Review of the February 2026 MAR showed insulin glargine and insulin lispro were repeatedly given in the right arm, left arm, rear upper arm, and abdomen-right upper quadrant. The LN stated insulin injection sites should be rotated to prevent bruising or hardening of the skin. The consultant pharmacist stated he reviewed residents’ MARs monthly to check whether medications were administered but did not check rotation of insulin injection sites. The DON stated insulin injection sites should be rotated to prevent side effects, tissue damage, and allow sites a chance to heal. The facility policy for Medication Administration required medications to be administered according to physician orders, current best practices, and federal and state regulations, and the Diabetic Care policy stated the facility would provide necessary care and services to diabetic residents, but it did not address rotation guidance for insulin administration sites. The facility also failed to reassess abnormal vital signs for Resident 126, who was admitted with metabolic encephalopathy and later died at the facility. The record showed a temperature of 72 degrees Fahrenheit taken orally at 5:22 p.m. and another temperature of 72 degrees Fahrenheit taken tympanically at 12:13 a.m. CNA31 stated that if a vital sign was out of range, staff would tell the nurses, and LN31 stated out-of-range vitals should be retaken and reported if still abnormal. The DON stated that if a vital sign is out of normal range, it should be repeated and, if it remains out of range, reported and a change of condition initiated; for this case, the early reading should have been re-evaluated. The facility’s vital signs policy stated vital signs are clinical measurements of basic body functions and are taken when there is a change in the resident’s condition.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.